References
- DeRemee RA. Serum lactic dehydrogenase activity and diffuse interstitial pneumonitis. JAMA 1968;204:1193–5.
- Matusiewicz SP, Williamson IJ, Sime PJ, Brown PH, Wenham PR, Crompton GK, et al. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic al-lergic alveolitis? Eur Respir J 1993;6:1282–6.
- Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Chin Oncol 1988;18:203–16.
- Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152(6 Pt 1):1860–6.
- Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activ-ity: sialylated carbohydrate antigen KL-6. Chest 1989;96:68–73.
- Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 1995;108:311–5.
- Hamada H, Sakatani M, Ueda E. KL-6 in patients with interstitial pneumonitis (in Japanese). Nihon Kyobu Shikkan Gakkai Zasshi 1996;34: 771–7.
- Kohno N. Clinical usefulness of KL-6 as a serum marker of idio-pathic interstitial pneumonia (in Japanese). Nihon Kyobu Shikkan Gakkai Zasshi 1996;34 Suppl:5186–9.
- Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakaki F, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Ftheumatol 2000;27:1164–70.
- Honda Y. Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia (in Japanese). Nihon Kyobu Shikkan Gakkai Zasshi 1996;34 Suppl:5181–5.
- Kitamura S, Hiwada K, Kobayashi J, Kohno N, Kawai T, Satou A, et al. Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis (in Japanese). Nihon Kyobu Shikkan Gakkai Zasshi 1996;34:639–45.
- Honda Y, Takahashi H, Abe S, Ando M, Kondo A, Ogasawara Y, et al. Clinical evaluation of surfactant protein D kit "Yamasa" in various lung diseases (in Japanese). Igaku to Yakugaku. 1996;36: 809–15.
- Kobayashi J, Itoh Y, Kitamura S, Kawai T. Establishment of refer- 16. ence intervals and cut-off value by enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia. Jpn J Clin Pathol 1996;44: 653–8.
- Kawasaki S, Takizawa H, Ito K. Computed tomography (CT) im- 17. ages of pulmonary lesions in collagen vascular disease (CVD) (in Japanese). Nichikyou 1996;55: 617–29.
- Schurawitzki H, Stiglbauer R, Graninger W, Herold C, Polzleitner D, Burghuber OC, et al. Interstitial lung disease in progressive 18. systemic sclerosis: high-resolution CT versus radiography. Radiol-ogy 1990;176: 755–9.
- Muller NL, Staples CA, Miller RR, Vedal S, Thurlbeck WM, Ostrow DN. Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation. Radiology 1987;165:731–4.
- Yokoyama A, Kohno N, Hamada H, Sakatani M, Ueda E, Kondo K, et al. Circulating KL-6 predicts the outcome of rapidly progres-sive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158(5 Pt 1):1680–4.
- Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997;17:501–7.